SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-017989
Filing Date
2016-05-05
Accepted
2016-05-05 16:22:50
Documents
45
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q acad-10q_20160331.htm 10-Q 1033562
2 EX-31.1 acad-ex311_10.htm EX-31.1 9130
3 EX-32.1 acad-ex321_11.htm EX-32.1 6381
  Complete submission text file 0001564590-16-017989.txt   2993452

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT acad-20160331.xml EX-101.INS 533509
5 XBRL TAXONOMY EXTENSION SCHEMA acad-20160331.xsd EX-101.SCH 22565
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acad-20160331_cal.xml EX-101.CAL 31309
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acad-20160331_def.xml EX-101.DEF 49886
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE acad-20160331_lab.xml EX-101.LAB 170570
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acad-20160331_pre.xml EX-101.PRE 125417
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

IRS No.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50768 | Film No.: 161624147
SIC: 2834 Pharmaceutical Preparations